A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder

References

• MerikangasKRJinRHeJPPrevalence and correlates of bipolar spectrum disorder in the world mental health survey initiativeArch Gen Psychiatry201168324125121383262
   PubMed Web of Science ®Google Scholar
• FittonAGoaKLLamotrigine. An update of its pharmacology and therapeutic use in epilepsyDrugs19955046917138536554
   PubMed Web of Science ®Google Scholar
• LiXKetterTAFryeMASynaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders? J Affect Disord2002691311412103447
   PubMed Web of Science ®Google Scholar
• PricaCHascoetMBourinMAntidepressant-like effect of lamotrigine is reversed by veratrine: a possible role of sodium channels in bipolar depressionBehav Brain Res20081911495418433891
   PubMed Web of Science ®Google Scholar
• GoldsmithDRWagstaffAJIbbotsonTPerryCMLamotrigine: a review of its use in bipolar disorderDrugs200363192029205012962521
   PubMed Web of Science ®Google Scholar
• SeoHJChiesaALeeSJSafety and tolerability of lamotrigine: results from 12 placebo-controlled clinical trials and clinical implicationsClin Neuropharmacol2011341394721242744
   PubMed Web of Science ®Google Scholar
• Lamictal^® (lamotrigine) tablets, chewable dispersible tablets, orally disintegrating tablets [prescribing information]. North Carolina: GlaxoSmithKline; Dec 2011; Revised 09/2012 Available from http://us.gsk.com/products/assets/us_lamictal.pdfAccessed November 24, 2012
   Google Scholar
• GoodwinGMfor Consensus Group of the British Association for PsychopharmacologyEvidence-based guidelines for treating bipolar disorder: revised second edition – recommendations from the British Association for PsychopharmacologyJ Psychopharmacol200923434638819329543
   PubMed Web of Science ®Google Scholar
• YathamLNKennedySHSchafferACanadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009Bipolar Disord200911322525519419382
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical ExcellenceBipolar Disorder: The Management of Bipolar Disorder in Adults, Children and Adolescents, in Primary and Secondary Care. NICE Clinical Guideline 38LondonNational Institute for Health and Clinical Excellence2006 [updated March 30, 2010] Available from http://www.nice.org.uk/nicemedia/live/10990/30193/30193.pdfAccessed September 10, 2012
   Google Scholar
• GrunzeHKasperSGoodwinGWorld Federation of Biological Psychiatry Task Force on Treatment Guidelines for Bipolar DisordersWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depressionWorld J Biol Psychiatry20023311512412478876
   PubMedGoogle Scholar
• GrunzeHKasperSGoodwinGWFSBP Task force on Treatment Guidelines for Bipolar DisordersThe World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Bipolar Disorders, Part II: Treatment of ManiaWorld J Biol Psychiatry20034151312582971
   PubMed Web of Science ®Google Scholar
• GrunzeHKasperSGoodwinGBowdenCMöllerHJWFSBP Task Force on Treatment Guidelines for Bipolar DisordersThe World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatmentWorld J Biol Psychiatry20045312013515346536
   PubMed Web of Science ®Google Scholar
• GrunzeHVietaEGoodwinGMWFSBP Task Force On Treatment Guidelines for Bipolar DisordersThe World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depressionWorld J Biol Psychiatry20101128110920148751
   PubMed Web of Science ®Google Scholar
• GrunzeHVietaEGoodwinGMThe World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute maniaWorld J Biol Psychiatry20091028511619347775
   PubMed Web of Science ®Google Scholar
• MokYMChanHNCheeKSMinistry of HealthMinistry of Health clinical practice guidelines: bipolar disorderSingapore Med J2011521291491891922159936
   PubMed Web of Science ®Google Scholar
• PfennigABschorTBaghaiTS3 guidelines on diagnostics and therapy of bipolar disorders: development process and essential recommendationsNervenarzt2012835568586 German22576049
   PubMed Web of Science ®Google Scholar
• AmannBBornCCrespoJMPomarol-ClotetEMcKennaPLamotrigine: when and where does it act in affective disorders? A systematic reviewJ Psychopharmacol201125101289129420823080
   PubMed Web of Science ®Google Scholar
• CiprianiABarbuiCSalantiGComparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysisLancet201137897991306131521851976
   PubMed Web of Science ®Google Scholar
• YildizAVietaELeuchtSBaldessariniRJEfficacy of anti-manic treatments: meta-analysis of randomized, controlled trialsNeuropsychopharmacology201136237538920980991
   PubMed Web of Science ®Google Scholar
• CalabreseJRBowdenCLSachsGSAscherJAMonaghanERuddGDA double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study GroupJ Clin Psychiatry1999602798810084633
   PubMed Web of Science ®Google Scholar
• GeddesJRCalabreseJRGoodwinGMLamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomized trialsBr J Psychiatry200919414919118318
   PubMed Web of Science ®Google Scholar
• CalabreseJRHuffmanRFWhiteRLLamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trialsBipolar Disord200810232333318271912
   PubMed Web of Science ®Google Scholar
• FryeMAKetterTAKimbrellTAA placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disordersJ Clin Psychopharmacol200020660761411106131
   PubMed Web of Science ®Google Scholar
• BrownEBMcElroySLKeckPEJrA 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depressionJ Clin Psychiatry20066771025103316889444
   PubMed Web of Science ®Google Scholar
• BrownEDunnerDLMcElroySLOlanzapine/fluoxetine combination vs lamotrigine in the 6-months treatment of bipolar I depressionInt J Neuropsychopharmacol200912677378219079815
   PubMed Web of Science ®Google Scholar
• SchafferAZukerPLevittARandomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depressionJ Affect Disord20069612959916844230
   PubMed Web of Science ®Google Scholar
• NolenWAKupkaRWHellemannGTranylcypromine vs lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful studyActa Psychiatr Scand2007115536036517430413
   PubMed Web of Science ®Google Scholar
• BowdenCLCalabreseJRSachsGLamictal 606 Study GroupA placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorderArch Gen Psychiatry200360439240012695317
   PubMed Web of Science ®Google Scholar
• CalabreseJRBowdenCLSachsGLamictal 605 Study GroupA placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorderJ Clin Psychiatry20036491013102414628976
   PubMed Web of Science ®Google Scholar
• GoodwinGMBowdenCLCalabreseJRA pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorderJ Clin Psychiatry200465343244115096085
   PubMed Web of Science ®Google Scholar
• vanderLoosMLMulderPGHartongEGEfficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trialJ Clin Psychiatry200970222323119200421
   PubMed Web of Science ®Google Scholar
• vanderLoosMLMulderPHartongEGfor LamLit Study GroupLong-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel designBipolar Disord201113111111721320258
   PubMed Web of Science ®Google Scholar
• ChangJSMoonEChaBHaKAdjunctive lamotrigine therapy for patients with bipolar II depression partially responsive to mood stabilizersProg Neuropsychopharmacol Biol Psychiatry20103471322132620673782
   PubMed Web of Science ®Google Scholar
• NierenbergAAOstacherMJCalabreseJRTreatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidoneAm J Psychiatry2006163221021616449473
   PubMed Web of Science ®Google Scholar
• IchimLBerkMBrookSLamotrigine compared with lithium in mania: a double-blind randomized controlled trialAnn Clin Psychiatry200012151010798820
   PubMedGoogle Scholar
• CalabreseJRSuppesTBowdenCLA double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorderJ Clin Psychiatry2000611184185011105737
   PubMed Web of Science ®Google Scholar
• BowdenCLCalabreseJRMcElroySLThe efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorderBiol Psychiatry199945895395810386176
   PubMed Web of Science ®Google Scholar
• SwartzHAThaseMEPharmacotherapy for the treatment of acute bipolar II depression: current evidenceJ Clin Psychiatry201172335636620816033
   PubMed Web of Science ®Google Scholar
• VietaECarnéXThe use of placebo in clinical trials on bipolar disorder: a new approach for an old debatePsychother Psychosom2005741101615627851
   PubMed Web of Science ®Google Scholar
• KetterTAGreistJHGrahamJARobertsJNThompsonTRNanryKPThe effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trialJ Clin Psychiatry200667340040616649826
   PubMed Web of Science ®Google Scholar
• GoldbergJFCalabreseJFSavilleBRMood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placeboJ Clin Psychiatry20097991273128019689918
   PubMed Web of Science ®Google Scholar
• LichtRWNielsenJNGramLFVestergaardPBendzHLamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6)Bipolar Disord201012548349320712749
   PubMed Web of Science ®Google Scholar
• SmithLACorneliusVWarnockATacchiMJTaylorDPharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trialsBipolar Disord20079655156017845269
   PubMed Web of Science ®Google Scholar
• FatemiSHRapportDJCalabreseJRThurasPLamotrigine in rapid-cycling bipolar disorderJ Clin Psychiatry199758125225279448654
   PubMed Web of Science ®Google Scholar
• HurleySCLamotrigine update and its use in mood disordersAnn Pharmacother200236586087311978166
   PubMed Web of Science ®Google Scholar
• KusumakarVYathamLNLamotrigine treatment of rapid cycling bipolar disorderAm J Psychiatry19971548117111729247416
   PubMed Web of Science ®Google Scholar
• WaldenJHesslingerBvan CalkerDBergerMAddition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorderPharmacopsychiatry19962951931958895945
   PubMed Web of Science ®Google Scholar
• WaldenJSchaererLSchloesserSGrunzeHAn open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilizationBipolar Disord20002433633911252647
   PubMed Web of Science ®Google Scholar
• WaldenJGrunzeHProspective, randomized study on valproate, lithium, valproate + lithium and lamotrigine in Bipolar I rapid cycling patientsProceedings of the SMRI Research Center conference November 8, 2002Bethesda, MD
   Google Scholar
• MainaGAlbertURossoGBogettoFOlanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot studyJ Clin Psychiatry200869460961618294024
   PubMed Web of Science ®Google Scholar
• SharmaVKhanMCorpseCRole of lamotrigine in the management of treatment-resistant bipolar II depression: a chart reviewJ Affect Disord2008111110010518314200
   PubMed Web of Science ®Google Scholar
• SuppesTMarangellLBBernsteinIHA single blind comparison of lithium and lamotrigine for the treatment of bipolar II depressionJ Affect Disord200811123334343
   Web of Science ®Google Scholar
• BowdenCLCalabreseJRKetterTASachsGSWhiteRLThompsonTRImpact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorderAm J Psychiatry200616371199120116816224
   PubMed Web of Science ®Google Scholar
• DossettECLandAJGitlinMJFryeMALack of mania prophylaxis associated with lamotrigine monotherapy in manic-predominant bipolar I disorderJ Clin Psychiatry200768697397417592931
   PubMed Web of Science ®Google Scholar
• GhaemiSNSchrauwenEKlugmanJLong-term lamotrigine plus lithium for bipolar disorder: One year outcomeJ Psychiatr Pract200612530030516998417
   PubMedGoogle Scholar
• MokhberNLaneCJAzarpazhoohMRAnticonvulsant treatments of dysphoric mania: a trial of gabapentin, lamotrigine and carbamazepine in IranNeuropsychiatr Dis Treat20084122723418728802
   PubMedGoogle Scholar
• NierenbergAACombined olanzapine plus fluoxetine modestly improves symptoms of acute bipolar I depression compared to lamotrigineEvid Based Ment Health20071011217255381
   PubMedGoogle Scholar
• RubioGLópez-MunozFAlamoCEffects of lamotrigine in patients with bipolar disorder and alcohol dependenceBipolar Disord20068328929316696832
   PubMed Web of Science ®Google Scholar
• SchieberFCBoultonDWBalchAHA non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorderHum Psychopharmacol200924214515219132712
   PubMed Web of Science ®Google Scholar
• SpauldingTWestlundRThomasonCWhiteRDannRThompsonTAdjunctive treatment for mood stabilization of patients with bipolar I disorder treated with lamotrigineCNS Spectr200611971171671916946696
   PubMed Web of Science ®Google Scholar
• CalabreseJRRapportDJYoungstromEAJacksonKBilaiSFindlingRLNew data on the use of lithium, divalproate, and lamotrigine in rapid cycling bipolar disorderEur Psychiatry2005202929515797691
   PubMed Web of Science ®Google Scholar
• JadadARMooreRACarrollDAssessing the quality of reports of randomized clinical trials: is blinding necessary?Control Clin Trials19961711128721797
   PubMedGoogle Scholar
• CalabreseJRBowdenCLMcElroySLSpectrum of activity of lamotrigine in treatment-refractory bipolar disorderAm J Psychiatry199915671019102310401445
   PubMed Web of Science ®Google Scholar
• ObroceaG VDunnRMFryeMAClinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disordersBiol Psychiatry200251325326011839368
   PubMed Web of Science ®Google Scholar